Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of CAPOX & Colorectal cancer (CRC), CAPOX is an established, guideline‑supported fluoropyrimidine–oxaliplatin regimen for colorectal cancer, and both components are individually approved by FDA and EMA for colorectal cancer indications (1, 2).
The data from six randomized phase III trials, conducted across 12 countries, were combined to analyze individual patient outcomes. The findings indicate that a three-month course of adjuvant CAPOX is beneficial for most patients with stage III colon cancer, as it supports overall survival. This recommendation is further reinforc…